Clinical Trials Logo

Aphasia clinical trials

View clinical trials related to Aphasia.

Filter by:

NCT ID: NCT04625790 Completed - Stroke Clinical Trials

Speech Therapy and Repetitive Transcranial Magnetic Stimulation Therapy in Post-stroke Anomic Aphasia

Start date: November 6, 2020
Phase: N/A
Study type: Interventional

The aim of the study is to observe the effects of speech therapy and transcranial magnetic stimulation therapy in patients who develop anomic aphasia after stroke. Patients meeting the inclusion criteria will be randomly divided into groups. In the repetitive transcranial magnetic stimulation (rTMS) treatment group, a total of 10 sessions, 1 session per day, will be applied to the right inferior frontal gyrus area with a frequency of 1 Hz for 20 minutes. The control group patients will be given speech therapy in the same way, but no active magnetic stimulation will be given in rTMS sessions (sham application). Speech therapy will be given to each patient by the same physiotherapist, and the treatment will last a total of 10 days, 60 minutes a day. Minimental test (MMT), Ege aphasia test, aphasia quality of life scale (SAQOL-39) will be filled in to the patients before and after the treatment.

NCT ID: NCT04623125 Completed - Aphasia, Acquired Clinical Trials

Spaced Retrieval as Treatment for Aphasia

Start date: October 1, 2020
Phase: N/A
Study type: Interventional

Spaced Repetition training has been found to be more effective than massed repetition for individuals with aphasia. This study seeks to examine the relative efficiency of three kinds of spacing for picture-naming training: traditional random presentation, non-adaptive spaced repetition, and adaptive spaced repetition.

NCT ID: NCT04620928 Completed - Aphasia Clinical Trials

Defining the Neural Dynamics of Concept Retrieval Using Electrocorticography

Start date: August 2, 2021
Phase: N/A
Study type: Interventional

This study will look at the way activity within the brain changes over time while a person is trying to think about certain everyday concepts. To measure brain activity accurately, we will be using electrodes placed on people's brains during awake brain surgery.

NCT ID: NCT04566081 Completed - Stroke Clinical Trials

Digital Interventions in Neurorehabilitation: iTALKbetter

Start date: October 14, 2019
Phase: N/A
Study type: Interventional

iTALKBetter will provide an app-based therapy for people with word retrieval difficulties who have had a stroke. This study aims to test the therapy application for people with naming difficulties through a small scale randomized controlled trial.

NCT ID: NCT04543084 Completed - Stroke Clinical Trials

Home Program Practice for People With Language Disorders After Stroke

Start date: January 22, 2021
Phase: N/A
Study type: Interventional

Logbooks are one of the most commonly used methods to both support and track adherence in research studies. This study will look at using logbooks to support adherence to reading practice for individuals with post-stroke aphasia. It is thought that using a logbook will increase practice time.

NCT ID: NCT04533308 Completed - Virtual Reality Clinical Trials

The Impact of Virtual Reality on the Emotional State of Patients With Aphasia During Rehabilitation.

Start date: August 20, 2020
Phase: N/A
Study type: Interventional

The aim of the study is to determine virtual reality (VR) impact during standard program of rehabilitation on emotional state of patients with aphasia.

NCT ID: NCT04488029 Completed - Aphasia, Acquired Clinical Trials

PCT for Speech, Language, and Cognitive Intervention in Stroke Patients

Start date: March 18, 2019
Phase: Phase 2
Study type: Interventional

Given the evolving uses of technology in rehabilitation, the investigators aimed to measure the change in aphasia severity using PCT App, a digital therapeutic adapted from Constant Therapy (CT), a dynamic, personalized therapy program for people with cognitive, speech, or language disorders. The entire study, including recruitment, enrollment, assessment and treatment were conducted remotely. The proposed pilot study seeks to compare performance of PCT therapy vs. conventional workbook intervention for stroke patients. The investigators hypothesize that the experimental (PCT) group will experience greater gains on the WAB-AQ at follow-up compared to baseline compared to a control (workbook) group. Subjects were prospectively assigned to an experimental or active control group in a random order with both groups balanced for their baseline level of speech, language and/or cognitive ability: 1. Experimental Group: Participants were instructed to use PCT for at least 30 minutes/day, 5 days/week. Performance and usage data were automatically reported by the PCT software to the treating clinician and was used to modify task assignment over time and monitor participant adherence to the treatment program. 2. Active Control Group: Participants were provided with a standard regime of paper workbooks (e.g. Workbook for Aphasia; Brubaker, 2006) that are typically used by clinicians with persons with aphasia (PWA) for at least 30 minutes/day, 5 days/week. Notably, the control procedure employed here is similar to a large-scale study examining technology as a treatment option by Palmer and colleagues (2015). The treatment period was 10 weeks. All participants received a bimonthly check-in through video-chat with a member of the research staff during the treatment period.

NCT ID: NCT04471935 Completed - Broca Aphasia Clinical Trials

Speech Hero Home Therapy for Aphasia

Start date: July 20, 2021
Phase: N/A
Study type: Interventional

The investigators will run an at-home usability study of a newly developed speech therapy app called Speech Hero with 10 individuals with Broca's aphasia in the chronic stage of stroke. The Speech Hero app allows users to perform rhythm-based speech exercises at home. For this study participants will be instructed to use Speech Hero for at least 10 hours over a 4-week period.

NCT ID: NCT04431401 Completed - Clinical trials for Primary Progressive Aphasia

rTMS Treatment of Primary Progressive Aphasia

Start date: July 1, 2020
Phase: N/A
Study type: Interventional

Primary Progressive Aphasia (PPA) is a neurodegenerative disease in which language function is gradually and progressively impaired. Patients will eventually be disabled in communication and have cognition deficits, which put a heavy burden not only on their families but also on the whole society. However, no effective treatment for PPA has been explored so far. The current clinical randomized trial is to study the safety and efficacy of repetitive Transcranial Magnetic Stimulation (rTMS) for the treatment of PPA. Also, multi-modality of neuroimaging techniques, such as functional MRI and PET will be used to investigate brain network changing in this procedure.

NCT ID: NCT04413136 Completed - Aphasia Clinical Trials

Web-Based Treatment for Aphasia

Web-ORLA
Start date: January 7, 2008
Phase: N/A
Study type: Interventional

This prospective randomized clinical trial implements an innovative broadband web-based treatment program for individuals with chronic aphasia, and evaluates its efficacy. The treatment, Oral Reading for Language in Aphasia (ORLA), has been shown to be efficacious when provided by a speech-language pathologist. The treatment has been computerized and the current version of ORLA uses state-of-the-art virtual therapist technology that allows the individual with aphasia to read aloud, and ultimately speak, sentences at the same time as the words are produced by a perceptive, life-like, animated computer agent, using visible speech. In this clinical trial, ORLA treatment is delivered via the internet and outcomes are compared to a placebo computer treatment.